157 related articles for article (PubMed ID: 35062873)
21. Is subdivision of pT2 tumors superior to lymph node metastasis for predicting survival of patients with gastric cancer? Review of 224 patients from four centers.
Bilici A; Dane F; Seker M; Ustaalioglu BB; Aliustaoglu M; Temiz S; Gezen C; Yavuzer D; Aksu G; Mayadagli A; Gumus M; Uygun K; Turhal NS
Dig Dis Sci; 2011 Nov; 56(11):3226-34. PubMed ID: 21660487
[TBL] [Abstract][Full Text] [Related]
22. Tumor size as a prognostic factor in patients with node-negative gastric cancer invading the muscularis propria and subserosa (pT2-3N0M0 stage).
Huang CM; Wang HM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J
Hepatogastroenterology; 2013 Jun; 60(124):699-703. PubMed ID: 23159390
[TBL] [Abstract][Full Text] [Related]
23. The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer.
Hermann GG; Horn T; Steven K
J Urol; 1998 Jan; 159(1):91-4. PubMed ID: 9400444
[TBL] [Abstract][Full Text] [Related]
24. Node-extranodal soft tissue stage based on extranodal metastasis is associated with poor prognosis of patients with gastric cancer.
Jiang N; Deng JY; Ding XW; Ke B; Liu N; Liang H
J Surg Res; 2014 Nov; 192(1):90-7. PubMed ID: 24953988
[TBL] [Abstract][Full Text] [Related]
25. Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach.
Wang HM; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J
World J Gastroenterol; 2012 Oct; 18(38):5470-5. PubMed ID: 23082065
[TBL] [Abstract][Full Text] [Related]
26. Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer.
Du CY; Chen JG; Zhou Y; Zhao GF; Fu H; Zhou XK; Shi YQ
World J Gastroenterol; 2012 Jul; 18(27):3610-6. PubMed ID: 22826628
[TBL] [Abstract][Full Text] [Related]
27. Long-term survival analysis of gastric cancer limited to the subserosa.
Lisborg PH; Jatzko GR; Denk H; Klimpfinger MH; Stettner HM
Z Gastroenterol; 1997 Sep; 35(9):663-8. PubMed ID: 9360292
[TBL] [Abstract][Full Text] [Related]
28. Surgical treatment of gastric cancer with special reference to lymph node removal.
Okajima K
Acta Med Okayama; 1977 Dec; 31(6):369-82. PubMed ID: 147606
[TBL] [Abstract][Full Text] [Related]
29. Prognostic analysis of submucosa-invasive gastric cancer with lymph node metastasis.
Hanyu T; Matsuki A; Kosugi S; Ishikawa T; Nashimoto A; Yabusaki H; Aizawa M; Ichikawa H; Shimada Y; Hirose Y; Wakai T
Surgery; 2015 Apr; 157(4):716-22. PubMed ID: 25433728
[TBL] [Abstract][Full Text] [Related]
30. Clinical Implication of Tumor-invasive Status into the Muscularis Propria in T2 Gastric Cancer.
Nakamura K; Ogimi M; Tomioku M; Hara H; Nabeshima K; Nomura E
In Vivo; 2019; 33(4):1341-1346. PubMed ID: 31280228
[TBL] [Abstract][Full Text] [Related]
31. Prognostic and clinical evaluation of patients with T2 gastric cancer.
Komatsu S; Ichikawa D; Kurioka H; Kan K; Shioaki Y; Ueshima Y; Hamashima T; Lee CJ; Ikeda E; Ueda Y; Otsuji E; Oka T; Yamagishi H
Hepatogastroenterology; 2005; 52(63):965-8. PubMed ID: 15966242
[TBL] [Abstract][Full Text] [Related]
32. Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer.
Bilici A; Seker M; Ustaalioglu BB; Yilmaz B; Doventas A; Salepci T; Gumus M
Med Oncol; 2010 Sep; 27(3):975-84. PubMed ID: 19885750
[TBL] [Abstract][Full Text] [Related]
33. Depth of
Seder CW; Mahon B; Hennon M; Thomas M; Levea CM; Matkowskyj KA; Krishna M; Medairos R; Macke RA; Basu S; Blasberg JD
Anticancer Res; 2018 Apr; 38(4):2195-2200. PubMed ID: 29599339
[TBL] [Abstract][Full Text] [Related]
34. Analysis of lymph node metastasis correlation with prognosis in patients with T2 gastric cancer.
Liu X; Long Z; Cai H; Huang H; Shi Y; Wang Y
PLoS One; 2014; 9(8):e105112. PubMed ID: 25136920
[TBL] [Abstract][Full Text] [Related]
35. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
36. Most important lymph node information in gastric cancer: multivariate prognostic study.
Adachi Y; Shiraishi N; Suematsu T; Shiromizu A; Yamaguchi K; Kitano S
Ann Surg Oncol; 2000 Aug; 7(7):503-7. PubMed ID: 10947018
[TBL] [Abstract][Full Text] [Related]
37. Accurate lymph node staging is of greater prognostic importance than subclassification of the T2 category for gastric adenocarcinoma.
Sarela AI; Turnbull AD; Coit DG; Klimstra D; Brennan MF; Karpeh MS
Ann Surg Oncol; 2003 Aug; 10(7):783-91. PubMed ID: 12900370
[TBL] [Abstract][Full Text] [Related]
38. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases.
Lai CH; Hong JH; Hsueh S; Ng KK; Chang TC; Tseng CJ; Chou HH; Huang KG
Cancer; 1999 Apr; 85(7):1537-46. PubMed ID: 10193944
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of subclassification of pT2 gastric cancer: a retrospective study of 847 patients.
Lu Y; Liu C; Zhang R; Li H; Lu P; Jin F; Xu H; Wang S; Chen J
Surg Oncol; 2008 Dec; 17(4):317-22. PubMed ID: 18586486
[TBL] [Abstract][Full Text] [Related]
40. Gastric carcinoma confined to the muscularis propria: how can we detect, evaluate, and cure intermediate-stage carcinoma of the stomach?
Nakamura K; Kamei T; Ohtomo N; Kinukawa N; Tanaka M
Am J Gastroenterol; 1999 Aug; 94(8):2251-5. PubMed ID: 10445558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
